Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 17.279% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) COC1=C/C(=C/c2c(N)n3nc(CC(=O)N4CCOCC4)sc3nc2=O)C=CC1=O
b.) CCOC(=O)C1CCN(S(=O)(=O)c2cn(C)c(=O)n(C)c2=O)CC1
c.) O=C(CSCCO)Nc1cccc(C(F)(F)F)c1
d.) O=C(NCc1cccs1)c1cc(S(=O)(=O)N2CCOCC2)c(Cl)cc1Cl
e.) O=S(=O)(Nc1cccc(Cl)c1)c1ccc2oc(=S)[nH]c2c1
Answer: b. CCOC(=O)C1CCN(S(=O)(=O)c2cn(C)c(=O)n(C)c2=O)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)C1CCN(S(=O)(=O)c2cn(C)c(=O)n(C)c2=O)CC1
CCOC(=O)C1CCN(S(=O)(=O)c2cn(C)c(=O)n(C)c2=O)CC1
ethyl 1-(1,3-dimethyl-2,4-dioxopyrimidin-5-yl)sulfonylpiperidine-4-carboxylate